Maarten F. Corsten

2.5k total citations · 1 hit paper
20 papers, 1.8k citations indexed

About

Maarten F. Corsten is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maarten F. Corsten has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Maarten F. Corsten's work include MicroRNA in disease regulation (7 papers), Viral Infections and Immunology Research (4 papers) and Cell death mechanisms and regulation (4 papers). Maarten F. Corsten is often cited by papers focused on MicroRNA in disease regulation (7 papers), Viral Infections and Immunology Research (4 papers) and Cell death mechanisms and regulation (4 papers). Maarten F. Corsten collaborates with scholars based in Netherlands, Belgium and United States. Maarten F. Corsten's co-authors include Blanche Schroen, Stéphane Heymans, Khalid Shah, Daniel R. Wagner, Yvan Devaux, Tatiana Kuznetsova, Robert Dennert, Jan A. Staessen, Sylvia H. J. Jochems and Randa Kasmieh and has published in prestigious journals such as Circulation Research, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Maarten F. Corsten

18 papers receiving 1.8k citations

Hit Papers

Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocar... 2010 2026 2015 2020 2010 200 400 600

Peers

Maarten F. Corsten
Ashish Yeri United States
Han Chung Chong Singapore
Hai Wu China
Temo Barwari United Kingdom
Jie Xiao China
Prabhu Mathiyalagan United States
Siyeon Rhee United States
Ashish Yeri United States
Maarten F. Corsten
Citations per year, relative to Maarten F. Corsten Maarten F. Corsten (= 1×) peers Ashish Yeri

Countries citing papers authored by Maarten F. Corsten

Since Specialization
Citations

This map shows the geographic impact of Maarten F. Corsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten F. Corsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten F. Corsten more than expected).

Fields of papers citing papers by Maarten F. Corsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten F. Corsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten F. Corsten. The network helps show where Maarten F. Corsten may publish in the future.

Co-authorship network of co-authors of Maarten F. Corsten

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten F. Corsten. A scholar is included among the top collaborators of Maarten F. Corsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten F. Corsten. Maarten F. Corsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corsten, Maarten F., et al.. (2024). Cold case: COVID-19-triggered type 1 cryoglobulinemia. Annals of Hematology. 103(10). 4305–4308.
2.
Aerts, Robina, Katrien Lagrou, Laurens Nieuwenhuizen, et al.. (2024). Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) Trial. Clinical Infectious Diseases. 80(2). 367–370. 1 indexed citations
3.
Jong, E.M.G.J. de, et al.. (2023). Evaluating the use of meropenem in hematologic patients with febrile neutropenia. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023067–e2023067.
4.
Blijlevens, Nicole M. A., Saskia K. Klein, W. M. Smit, et al.. (2022). P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.. HemaSphere. 6. 604–605. 6 indexed citations
5.
Corsten, Maarten F., Ward Heggermont, Anna‐Pia Papageorgiou, et al.. (2015). The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. European Heart Journal. 36(42). 2909–2919. 93 indexed citations
6.
Heggermont, Ward, Maarten F. Corsten, Hendrik Jan Thibaut, et al.. (2013). The microRNA 221/222 cluster controls CVB3-induced myocarditis: could tiny microRNAs explain adverse inflammation in the heart?. European Heart Journal. 34(suppl 1). 5866–5866. 1 indexed citations
7.
Schroen, Blanche, Maarten F. Corsten, Wouter Verhesen, et al.. (2012). Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure. Cardiovascular Research. 93. 2 indexed citations
8.
Heggermont, Ward, Paolo Carai, Lucas Van Aelst, et al.. (2012). Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertrophy and hypertensive heart failure, and a promising therapeutic target. European Heart Journal Supplements. 33. 115–115. 1 indexed citations
9.
Corsten, Maarten F., Blanche Schroen, & Stéphane Heymans. (2012). Inflammation in viral myocarditis: friend or foe?. Trends in Molecular Medicine. 18(7). 426–437. 100 indexed citations
10.
Corsten, Maarten F., Anna Papageorgiou, Wouter Verhesen, et al.. (2012). MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis. Circulation Research. 111(4). 415–425. 168 indexed citations
11.
Devaux, Yvan, Mélanie Vausort, Emeline Goretti, et al.. (2012). Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction. Clinical Chemistry. 58(3). 559–567. 210 indexed citations
12.
Corsten, Maarten F., Robert Dennert, Sylvia H. J. Jochems, et al.. (2011). Response to Letter Regarding Article, “Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease”. Circulation Cardiovascular Genetics. 4(1). 1 indexed citations
13.
Corsten, Maarten F., Robert Dennert, Sylvia H. J. Jochems, et al.. (2010). Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(6). 499–506. 638 indexed citations breakdown →
14.
Corsten, Maarten F., et al.. (2010). Optical Characterization of Arterial Apoptosis. Methods in molecular biology. 680. 117–129. 3 indexed citations
15.
Laufer, Eduard M., et al.. (2009). PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.. PubMed. 53(1). 26–34. 37 indexed citations
16.
Corsten, Maarten F. & Khalid Shah. (2008). Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. The Lancet Oncology. 9(4). 376–384. 106 indexed citations
17.
Corsten, Maarten F., Rafael Abe da Rocha Miranda, Randa Kasmieh, et al.. (2007). MicroRNA-21 Knockdown Disrupts Glioma Growth In vivo and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human Gliomas. Cancer Research. 67(19). 8994–9000. 330 indexed citations
18.
Corsten, Maarten F., et al.. (2007). Cardiovascular molecular imaging of apoptosis. European Journal of Nuclear Medicine and Molecular Imaging. 34(S1). 86–98. 27 indexed citations
19.
Corsten, Maarten F., Chris Reutelingsperger, & Leonard Hofstra. (2007). Imaging apoptosis for detecting plaque instability: rendering death a brighter facade. Current Opinion in Biotechnology. 18(1). 83–89. 11 indexed citations
20.
Corsten, Maarten F., Leonard Hofstra, Jagat Narula, & Chris Reutelingsperger. (2006). Counting Heads in the War against Cancer: Defining the Role of Annexin A5 Imaging in Cancer Treatment and Surveillance. Cancer Research. 66(3). 1255–1260. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026